Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01

STAFFORD, Texas, July 09, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the use of commercially manufactured GP2 in FLAMINGO-01 in Europe.

Monaco Energy Boat Challenge sets sail with 54 teams driving sustainable innovation

MONACO, July 09, 2026 (GLOBE NEWSWIRE) — The 13th Monaco Energy Boat Challenge gets underway from 8–11 July 2026, bringing together 54 teams from 21 countries at the Yacht Club de Monaco Marina to showcase the latest advances in sustainable marine technology. Organized by the Yacht Club de Monaco with the support of the Prince Albert II of Monaco Foundation, UBS, BMW, SBM Offshore, Monaco City Hall, NatPower H and ESA NanoTech, the event has become a leading international platform for innovation in clean propulsion.

Monaco Energy Boat Challenge connects young talent with the marine industry

MONACO, July 09, 2026 (GLOBE NEWSWIRE) — With the Monaco Energy Boat Challenge about to begin, 54 teams are making their final preparations on the quay of the Yacht Club de Monaco before the competition gets underway. From 8–11 July, students, researchers, engineers, manufacturers and shipyards from around the world gather in the Principality to test, share and compare solutions for next-generation propulsion systems.